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Abstract. 
 
The 
 
a
 
v
 
b
 
3
 
 integrin plays a fundamental role 
during the angiogenesis process by inhibiting endothe-
lial cell apoptosis. However, the mechanism of inhibi-
tion is unknown. In this report, we show that integrin-
mediated cell survival involves regulation of nuclear 
factor-kappa B (NF-
 
k
 
B) activity. Different extracellu-
lar matrix molecules were able to protect rat aorta-
derived endothelial cells from apoptosis induced by se-
rum withdrawal. Osteopontin and 
 
b
 
3
 
 integrin ligation 
rapidly increased NF-
 
k
 
B activity as measured by gel 
shift and reporter activity. The p65 and p50 subunits 
were present in the shifted complex. In contrast, col-
lagen type I (a 
 
b
 
1
 
-integrin ligand) did not induce NF-
 
k
 
B 
activity. The 
 
a
 
v
 
b
 
3
 
 integrin was most important for os-
teopontin-mediated NF-
 
k
 
B induction and survival, 
since adding a neutralizing anti-
 
b
 
3 
 
integrin antibody 
blocked NF-
 
k
 
B activity and induced endothelial cell 
death when cells were plated on osteopontin. NF-
 
k
 
B 
was required for osteopontin- and vitronectin-induced 
survival since inhibition of NF-
 
k
 
B activity with non-
phosphorylatable I
 
k
 
B completely blocked the protec-
tive effect of osteopontin and vitronectin. In contrast, 
NF-
 
k
 
B was not required for fibronectin, laminin, and 
collagen type I–induced survival. Activation of NF-
 
k
 
B 
by osteopontin depended on the small GTP-binding 
protein Ras and the tyrosine kinase Src, since NF-
 
k
 
B 
reporter activity was inhibited by Ras and Src domi-
nant-negative mutants. In contrast, inhibition of MEK 
and PI3-kinase did not affect osteopontin-induced 
NF-
 
k
 
B activation. These studies identify NF-
 
k
 
B as an 
important signaling molecule in 
 
a
 
v
 
b
 
3
 
 integrin-mediated 
endothelial cell survival.
 
I
 
n
 
 recent years it has become evident that integrin-
mediated adhesion to extracellular matrix (ECM)
 
1
 
proteins is required for growth and survival of many
cell types. Adhesion to ECM is required for progression of
cells through the cell cycle by regulating cyclinD1, cyclinE-
Cdk2, and Rb protein activities (Fang et al., 1996). Disrup-
tion of adhesion arrests cells in the G1 phase and causes
apoptosis (Boudreau et al., 1996; Frisch and Francis, 1994;
Howlett and Bissell, 1993; Ingber et al., 1995; Meredith et al.,
1993; Re et al., 1994). The requirement of cell–ECM adhe-
sive interactions for cell cycle progression and cell survival
is likely to be important in tissue development and involu-
tion as a mechanism to regulate cell positioning and cell
number (Lin and Bissell, 1993). In addition, anchorage de-
pendence of survival may serve to limit tumor progression
by preventing invasion or metastasis of tumor cells (Var-
ner and Cheresh, 1996). Integrin-regulated survival prop-
erties have also been shown to be relevant in wound repair
since integrin antagonists induced apoptosis of migrating
endothelial cells, thereby blocking angiogenesis (Brooks
et al., 1994
 
a
 
; Brooks et al., 1994
 
b
 
; Friedlander et al., 1996).
The mechanism by which integrin-mediated ECM adhe-
sion is able to prevent apoptosis is unclear and under in-
tense investigation. Focal adhesion kinase (FAK) is phos-
phorylated in response to cell adhesion, and constitutively
activated membrane-targeted FAK was able to rescue
cells from suspension-induced cell death (Frisch et al.,
1996
 
b
 
). The JNK pathway is active in detached epithelial
cell (Frisch et al., 1996
 
a
 
), and the Ras, PI3-kinase, Akt
pathways are activated and functionally implicated in cell
attachment–induced survival (Khwaja et al., 1997). Two
groups suggest that integrin engagement positively regu-
lates expression of the antiapoptotic gene 
 
bcl-2
 
 in COS
and endothelial cells (Stromblad et al., 1996; Zhang et al.,
1995). In addition, Stromblad et al. showed that 
 
a
 
v
 
b
 
3
 
 en-
gagement and clustering in endothelial cells, but not 
 
b
 
1
 
 or
 
a
 
v
 
b
 
5
 
 ligation, conferred an antiapoptotic phentoype to en-
dothelial cells. Importantly, the same group showed that
inhibition of angiogenesis by anti-
 
a
 
v
 
b
 
3
 
 antibody correlates
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with angiogenic endothelial cell apoptosis (Brooks et al.,
1994
 
b
 
).
The transcription factor nuclear factor-kappa B (NF-
 
k
 
B)
is a pleiotropic regulator of many genes involved in im-
mune and inflammatory responses. The NF-
 
k
 
B family of
proteins consists of homo- or heterodimeric subunits of
the Rel family, including p50 and p65. In unstimulated
cells, most of the NF-
 
k
 
B is localized in the cytoplasm in
complex with an inhibitory protein, I
 
k
 
B
 
 
 
(Baldwin, 1996).
Upon stimulation, the inhibitory I
 
k
 
B becomes phosphory-
lated, ubiquinated, and subsequently degraded by the pro-
teosome machinery
 
 
 
(Palombella et al., 1994). This allows
NF-
 
k
 
B to translocate to the nucleus, bind DNA, and trans-
activate transcription of specific genes. Recently, several
lines of evidence have suggested that NF-
 
k
 
B is an impor-
tant cell survival factor
 
 
 
(Beg and Baltimore, 1996; Liu et
al., 1996; Van Antwerp et al., 1996; Wang et al., 1996).
However, integrin-mediated survival has never been func-
tionally linked to NF-
 
k
 
B activation.
In the present study, we explored the possibility that in-
tegrin-mediated endothelial cell survival is controlled by
NF-
 
k
 
B activation. Our experiments indicate that different
ECM molecules, including osteopontin, promote endothe-
lial cell survival upon serum deprivation. Moreover, adhe-
sion of endothelial cells to the 
 
a
 
v
 
b
 
3
 
 ligand osteopontin in-
creases nuclear NF-
 
k
 
B activity. Furthermore, we find that
 
b
 
3
 
 integrin mediates osteopontin’s protective effect and
NF-
 
k
 
B activation. Most importantly, we show that the os-
teopontin and vitronectin-mediated cell protective effect
is abolished by inhibiting NF-
 
k
 
B nuclear translocation.
Thus, NF-
 
k
 
B activation is required for endothelial cell
protective effects of 
 
a
 
v
 
b
 
3
 
 ligands after serum deprivation–
induced apoptosis.
 
Materials and Methods
 
Materials
 
Recombinant wild-type and RGE-mutant mouse osteopontin were ex-
pressed in 
 
Escherichia
 
 
 
coli
 
 as glutathione 
 
S
 
-transferase fusion proteins as
previously described
 
 
 
(Liaw et al., 1995). Purified bovine plasma fibronec-
tin was obtained from GIBCO BRL (Gaithersburg, MD); purified rat
plasma vitronectin was obtained from Sigma Chemical Co. (St. Louis,
MO); purified mouse laminin and rat tail collagen type I were obtained
from Collaborative Biomedical Products (Bedford, MA), and polylysine
was obtained from Sigma Chemical Co. Mouse monoclonal antibody F11
directed against the rat 
 
b
 
3
 
 integrin, and hamster monoclonal antibody
Ha2/5 directed against the rat 
 
b
 
1
 
 integrin were obtained from PharMingen
(San Diego, CA). Rabbit polyclonal antibodies against NF-
 
k
 
B p65, p50
subunits were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Rabbit polyclonal antibody against poly(ADP-ribose) polymerase was ob-
tained from Upstate Biotechnology Inc. (Lake Placid, NY). Constructs
containing the 
 
fos
 
 gene core promoter by itself (pfLUC) or fused to two
NF-
 
k
 
B sites derived from the Ig
 
k
 
 promoter (pBIIX-LUC) driving the lu-
ciferase gene were a kind gift from D. Baltimore (Massachusetts Institute
of Technology, Boston, MA). Dominant negative constructs for Ras
(RasN17) and Src (kinase-dead) were a kind gift of Dr. Berk (University
of Washington, Seattle, WA). The LY-294002 compound was purchased
from Biomol Research Laboratories, Inc. (Plymouth Meeting, PA), and
the PD98059 was purchased from Calbiochem-Novabiochem Corp. (La
Jolla, CA).
 
Cell Cultures
 
Rat aortic endothelial cells (RAEC) were isolated as previously described
(Nicosia et al., 1994). Cells were routinely maintained in MCBD 131 me-
dium (GIBCO BRL), supplemented with 10mM 
 
l
 
-glutamine, 10% FCS
(HyClone Laboratories Inc., Logan, UT), and 100 U/ml each penicillin
and streptomycin (GIBCO BRL). Cells were passaged by detaching with
0.05% trypsin and maintained at 37
 
8
 
C with 5% CO
 
2
 
. For all experiments,
cells were used between passage 15 and 25. Human microvascular endo-
thelial cells were obtained from Clonetics (San Diego, CA).
 
Survival Assay
 
Cells were detached, and equal numbers were replated on permanox
slides (Nalge Nunc International, Pittsburgh, PA) either left uncoated or
coated with different substrates. Substrates were diluted in PBS and
coated onto permanox slides overnight at 4
 
8
 
C. Substrates were used at
concentrations giving maximal adhesion and survival. Osteopontin was
used at 100 nM; fibronectin, vitronectin, and laminin at 50 nM; collagen
type I at 5 
 
m
 
g/ml; and F11 at 500 
 
m
 
g/ml. For the inhibition experiment, an-
tibodies were diluted in serum-free medium and added to the cells 
 
z
 
2 h
after plating. F11 was used at 50 
 
m
 
g/ml; nonimmune mouse IgG at 50 
 
m
 
g/ml;
Ha2/5 at 10 
 
m
 
g/ml; and nonimmune hamster IgM at 10 
 
m
 
g/ml. 48 h after
plating, nuclei were stained with the membrane-permeant dye Hoechst
33342 (Molecular Bioprobes, Eugene, OR). Live cells were incubated for
30 min at 37
 
8
 
C with a 4 
 
m
 
g/ml solution of the dye. Cells were then fixed
with 4% paraformaldehyde and viewed with a fluorescence microscope.
Experiments were repeated at least three times. For AnnexinV staining,
10
 
6
 
 cells were plated on osteopontin- and polylysine-coated 60-mm tissue
culture dishes. 24 and 48 h after plating, cells were detached and incubated
with AnnexinV-FITC (PharMingen) according to the manufacturer’s in-
structions and analyzed by flow cytometry.
 
Western Blot
 
Proteins were extracted from cell monolayers in Laemmli’s buffer con-
taining protease inhibitors (0.2 
 
m
 
g/ml aprotinin, 0.2 
 
m
 
g/ml leupeptin, and
0.1 mM PMSF). After centrifugation and boiling, protein concentration
was measured using the MicroBCA assay (Pierce, Rockford, IL). 50 
 
m
 
g of
total protein were loaded onto 9% SDS-polyacrylamide gel for poly
(ADP-ribose) polymerase (PARP) detection. Gels were transferred to a
polyvinyldene difluoride membrane (Dupont-NEN, Boston, MA). Perox-
idase-conjugated goat anti–rabbit antibody (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA) was used as secondary antibody. Pro-
teins were visualized by adding chemiluminescence reagent according to
the manufacturer’s instructions (Dupont-NEN).
 
Electrophoretic Mobility Shift Assay (EMSA)
 
Gel shift assays were performed as described by Qwarnstrom et al. (1994).
A double-stranded oligonucleotide containing the DNA-binding site for
the NF-
 
k
 
B proteins (5
 
9
 
AGTTGAGGGGACTTTCCCAGGC 3
 
9
 
) was ob-
tained from Promega Corp. (Madison, WI), and was end-labeled using
[
 
g
 
32
 
P]ATP according to the manufacturer’s protocol (Promega Corp.) and
purified using a Sephadex G-25 column (Pharmacia Biotech, Inc., Piscat-
away, NJ). The binding assay for the proteins was carried out as previ-
ously described (Guo et al., 1995). In brief, nuclear extracts were obtained
using a modified Dignam protocol (Lee et al., 1988). Cells were scraped,
washed with PBS, and resuspended in 20 
 
m
 
l of buffer A (10 mM Hepes,
pH 7.9, 10 mM KCl, 1.5 mM MgCl
 
2
 
, and 0.5 mM EDTA, pH 8.0) and al-
lowed to swell on ice for 20 min. The nuclei were separated from the cell
lysate by centrifugation at 12,000 
 
g
 
 for 5 min in a microfuge. This nuclear
pellet was resuspended in 20 
 
m
 
l of buffer C (20 mM Hepes, pH 7.9, 420 mM
NaCl, 15 mM MgCl
 
2
 
, 0.2 mM EDTA, pH 8.0, 25% glycerol, 0.5 mM
PMSF, and 0.5 mM DTT), and incubated for 10 min in ice. The lysed nu-
clei were centrifuged for 5 min at 4
 
8
 
C at 12,000 
 
g
 
 in a microfuge. The nu-
clear extracts were assayed for protein content using the Biorad assay
method. Aliquots of the extracts were used for the gel-shift assay, or were
quick-frozen in dry ice and stored at 
 
2
 
70
 
8
 
C. 5–10 
 
m
 
g of nuclear extracts
were mixed with 60,000–80,000 cpm of labeled probe along with 300 
 
m
 
g/ml
BSA and 133 
 
m
 
g/ml poly dIdC.dIdC (to prevent nonspecific binding). The
binding reaction was carried out at room temperature for 15 min, and the
samples were run on a 4% nondenaturing acrylamide gel. Reactions con-
taining competitive and uncompetitive oligonucleotides used 10 
 
m
 
g of nu-
clear extract, and were preincubated for 15 min before adding the labeled
probe. For supershift EMSA, the samples were incubated with 6 
 
m
 
l of the
proper antibodies for 45 min just before running. The gels were dried, and
bands were detected by autoradiography.Scatena et al. NF-kB and Integrin-mediated Cell Survival 1085
Transfections and Reporter Assays
For transfections, 2 3 106 cells in 100-mm dishes were transfected with 10 mg
of DNA, using SuperFect™ (QIAGEN Inc., Chatsworth, CA). For
cotransfection experiments, equal molar amounts of each plasmid were
used for a total of 10 mg of DNA per 100-mm dish. Cells were allowed to
recuperate overnight, and were then trypsinized and plated either on os-
teopontin or polylysine-coated surfaces in serum free medium. Cells were
harvested 8 h after plating, and luciferase activity was measured using a
luciferase assay system (Promega Corp.) according to the manufacturer’s
instructions. As a control, transfected cells were treated with IL1-b or ve-
hicle for 1 h. Luciferase activity was normalized relative to human growth
hormone secretion as described (Allegro Inc., Madison, WI). Experiments
were repeated at least three times.
Immunocytochemistry
Cells were plated either on osteopontin or polylysine-coated permanox
slides (Nalge Nunc International) in serum-free medium. 2 h after plating,
cells were rinsed with PBS and fixed with cold methanol for 5 min. Endog-
enous peroxidases were blocked with 0.1% hydrogen peroxide in metha-
nol for 10 min. After rinsing with PBS, nonspecific binding was minimized
by blocking with 1.5% normal rabbit serum in PBS. Anti-NF-kB p65
polyclonal antibody at the concentration of 1 mg/ml was used as primary
antibody. A biotinylated anti–rabbit antibody was then applied, followed
by an avidin-peroxidase conjugate (ABC Elite; Vector Labs, Inc., Burlin-
game, CA). 3,39diaminobenzidine was used as detection substrate. Cells
were counterstained with Fast Red.
Construction of Nonphosphorylatable IkB Construct 
and Development of Stable Cell Lines
Murine IkBa cDNA was obtained from Paul Noble (Johns Hopkins,
Baltimore, MD). Specific oligonucleotide primers (59TTGGGATCCA-
TGGACTACAAAGACGATGACGATAAAATGAAGGACGACGAG-
TACGACC39 and 59CCAGGATCCACTTATAATGTCAGACGCTGG-
CCT39) were used to construct an IkBa deletion mutant lacking amino
acids 1–37, and to insert a FLAG sequence in frame with amino acid 37.
The PCR product was initially cloned in the pCR2.1 vector (Invitrogen
Corp., Carlsbad, CA) and then subcloned into the MREpNeo vector
(MREpNeoDN; Searle et al., 1985). Stable lines were obtained by trans-
fecting endothelial cells with MREpNeoDN using SuperFect™ (Qiagen
Inc.). Cells were selected for 10 d with medium containing 500 mg/ml of
G418 and 10% Zn-depleted serum (Searle et al., 1985). Five independent
clones were isolated. All experiments were repeated with two indepen-
dent clones (REACDN2 and REACDN5). Cell lines were routinely main-
tained in medium containing 10% Zn-depleted serum.
Results
Osteopontin Rescues Endothelial Cells from Serum 
Deprivation–induced Apoptosis
Adhesion to ECM via integrin receptors has previously
been shown to protect endothelial cells from suspension-
induced apoptosis (Meredith et al., 1993; Re et al., 1994).
We now show that ECM may also play a role in cell sur-
vival under conditions of serum deprivation. Rat aortic en-
dothelial cells were plated in serum-containing medium
and allowed to spread for z2 h. Immediately after spread-
ing, the media was changed to serum-free media, and nu-
clei were scored for fragmentation 48 h after plating. As
shown in Fig. 1, cells plated on osteopontin-coated sur-
faces showed a minimal (,5%) rate of cell death after
growth factor withdrawal (Fig. 1). In contrast, cells plated
on uncoated surfaces showed 30% cell death. 30% cell
death was also observed when cells were plated on a form
of osteopontin carrying an inactivating mutation at the
RGD sequence, suggesting an integrin-mediated mecha-
nism. Similar results were obtained using human microvas-
cular endothelial cells (data not shown).
We then asked if other ECM molecules would promote
endothelial cell survival in the same system. We tested vit-
ronectin, fibronectin, laminin, and collagen type I, and all
were able to protect endothelial cells from growth factor
withdrawal–induced death (data not shown). Since lami-
nin and collagen type I primarily interact with b1-contain-
ing integrins, these results suggest that different integrin
dimers are able to protect from serum deprivation–induced
apoptosis.
The condensed and fragmented nuclear morphology of
the cells scored as dead suggested apoptosis as the mecha-
nism of cell death (Fig. 2, A and B). To obtain a more
quantitative assessment of cell death and to verify that apop-
tosis was indeed the mechanism of cell death, we took sev-
eral approaches. First, fluorescently labeled AnnexinV
(PharMingen, San Diego, CA) was used. AnnexinV binds
to the membrane lipid phosphatidylserine, which is trans-
located to the outer layer of the plasma membrane in cells
undergoing apoptosis (Vermes et al., 1995). The results
summarized in Table I show a time-dependent increase in
AnnexinV binding when cells were plated on polylysine,
but not on osteopontin, confirming that the ECM molecule
osteopontin promotes endothelial cell survival. Second,
we confirmed that caspases were involved in endothelial
apoptosis in the absence of serum. The poly (ADP-ribose)
polymerase PARP, an enzyme that facilitates repair of DNA
strand breaks, is a substrate for caspases. When caspases
are active, PARP is cleaved in a typical pattern (Tewari et
al., 1995). As shown in Fig. 2, C and D, cells plated on os-
teopontin demonstrated less PARP cleavage than cells
plated on polylysine. These findings strongly suggest that
caspase-dependent apoptosis after serum deprivation is
the mechanism of death.
b3-containing Integrin Mediates
Osteopontin-induced Survival
We previously showed that the avb3 integrin mediates en-
Figure 1. Osteopontin protects endothelial cells from serum de-
privation–induced cell death. Endothelial cells were plated in se-
rum on uncoated plastic, or on plastic coated with recombinant
wild-type osteopontin (OPN), or osteopontin containing a RGD
to RGE mutation (OPN-RGE). Soon after spreading (z2 h after
plating), the serum was withdrawn. 48 h after plating, cells were
stained with the nuclear dye Hoechst 33342, and nuclear frag-
mentation was assessed. In control cultures, serum was not with-
drawn from the cells. Data represent the average of triplicates 6
SD of a representative experiment.The Journal of Cell Biology, Volume 141, 1998 1086
dothelial cell adhesion and migration to osteopontin (Liaw
et al., 1995). To examine if avb3 was involved in osteopon-
tin’s survival function, endothelial cells were plated in se-
rum-free medium on an osteopontin-coated surface, and
were allowed to adhere and spread. Cells were then chal-
lenged with either neutralizing integrin subunit antibodies
or nonimmune IgG. As shown in Fig. 3 A, treatment with
the anti-b3 integrin antibody (F11) caused time-dependent
endothelial cell death. The level and the time course of cell
death were comparable to those of cells plated on poly-
lysine alone (data not shown). In contrast, cells treated
with a nonimmune mIgG or an anti-b1 neutralizing anti-
body (Ha2/5; data not shown) were fully protected by os-
teopontin. The F11 antibody used in this study is directed
against the b3-integrin subunit. Since no known integrin
subunit other than av can dimerize with b3 in nucleated
cells, it is likely that this integrin subunit is heterodimer-
ized to av. This fact suggests that osteopontin’s protective
effect was mediated by avb3. To confirm this finding, we
asked whether b3 ligation and clustering by surface-immo-
bilized F11 could prevent cell death. As shown in Fig. 3 B,
F11 was as effective as osteopontin in promoting cell sur-
vival, thus strongly suggesting that signaling through avb3
receptor was involved.
To determine whether avb3 was involved in the protec-
tive effects of other ECM proteins, we used vitronectin, fi-
bronectin, and laminin as substrates in a second set of sim-
ilar experiments. As expected, treatment with F11 antibody
induced cell death when endothelial cells were plated on
vitronectin, but not when cells were plated on fibronectin
and laminin (data not shown). Ha2/5 antibody was able to
inhibit laminin-induced cell survival, but the combination
of the two neutralizing antibodies was necessary in order
to inhibit fibronectin-induced survival (data not shown).
These findings suggest that the avb3 integrin is involved in
osteopontin and vitronectin-mediated endothelial cell sur-
vival, that a b1-containing integrin-mediated laminin in-
duced cell survival, and finally that fibronectin was able to
use both a avb3- or b1-containing integrin receptor to sig-
nal survival.
Endothelial Cell Adherence to Osteopontin Induces 
NF-kB Activation
The p65 subunit of the NF-kB transcription factor has
been shown recently to be necessary for cell survival (Beg
and Baltimore, 1996; Liu et al., 1996; Van Antwerp et al.,
1996; Wang et al., 1996). We hypothesized that adhesion
of endothelial cells to an ECM substrate was capable of
activating the NF-kB pathway, thereby activating a protec-
Figure 2. Endothelial cells
plated on osteopontin do not
show nuclear fragmentation.
(A and B) Cells were plated
on polylysine- (A) or osteopon-
tin- (B) coated surfaces in se-
rum-free medium. 48 h after
plating, cells were stained
with the nuclear dye Hoechst
33342, and nuclear morphol-
ogy was assessed by fluores-
cence microscope. Arrows in-
dicate the apoptotic nuclei.
Bar, 40 mM. (C) Cells were
plated on polylysine- (PDL)
or osteopontin- (OPN) coated
surfaces in serum-free me-
dium. Proteins were extracted
6 and 24 h after plating, elec-
trophoresed, Western blotted,
and probed with an anti-PARP
antibody. Arrows indicate
uncleaved (115 kD) and
cleaved (85 kD) forms. (D)
The relative intensity of 115
kD and 85 kD was determined
with ImageQuant software
(Molecular Dynamics, Inc.,
Sunnyvale, CA), and the per-
centage of cleaved product
(85 kD band) was plotted.
Table I. AnnexinV Staining
% negative (peak mean) % positive (peak mean)
OPN
24 h 90.6 (62.59) 9.4 (106.2)
48 h 88.9 (92.36) 11.1 (186.97)
PDL
24 h 69.9 (76.11) 30.4 (145.01)
48 h 50.2 (105.52) 49.08 (192.25)
Cells were plated on osteopontin (OPN) or polylysine (PDL). 24 and 48 h after plat-
ing, cells were harvested and stained with AnnexinV-FITC and analyzed by flow cy-
tometry. Negative and positive percentage values at the two timepoints are indicated.
In addition, the peak mean (in parentheses) is also indicated.Scatena et al. NF-kB and Integrin-mediated Cell Survival 1087
tive pathway in the cell. To test this hypothesis, we used
three different approaches. First, endothelial cells were
plated on osteopontin or polylysine-coated surfaces. Nu-
clear extracts were prepared at various time points, and
NF-kB activity was examined by EMSA. As shown in Fig.
4 A, nuclear extract prepared from endothelial cells plated
on osteopontin contained significant levels of NF-kB con-
sensus oligomer-binding activity. In contrast, control cells
showed very little activity (Fig. 4 A). The DNA–protein
complex formed in cells adherent to osteopontin was spe-
cific, since excess unlabeled NF-kB consensus oligomer in-
hibited, whereas an unrelated sequence had no effect (Fig.
4 A). In contrast, the pure b1–integrin ligand, collagen type
I, did not induce NF-kB binding activity, as shown in Fig. 4
B. As expected, the mixed ligand fibronectin, which can
interact with both b3 and b1 integrins, was able to induce
NF-kB binding activity (Fig. 4 B). Finally, the osteopontin-
induced NF-kB–binding activity was sustained up to 8 h
(Fig. 4 C).
The transcription factor Rel family of genes is composed
of several NF-kB protein subunits (p65 or RelA, p50/p105
or NF-kB1, p52/p100 or NF-kB2, RelB, and the protoon-
cogene c-rel; Baldwin, 1996). To establish the composition
of the band that was shifted, we performed super-shift
EMSA using direct antibodies against the p65, p50, p52,
and c-rel subunits. As shown in Fig. 5, the shifted complex
formed when the cells were plated on an osteopontin-
coated surface was composed of the p65 and p50 NF-kB
subunits, since the combination of these antibodies com-
pletely ablated the primary band. Antibodies directed
against the p52 and c-rel subunits did not affect the pri-
mary band (data not shown). Second, we used a reporter
construct containing two NF-kB consensus binding sites in
the promoter in order to verify that NF-kB was transcrip-
tionally active. A fourfold induction of the reporter con-
struct was observed when cells were plated on osteopontin
and fibronectin compared with control polylysine (Fig. 6).
In contrast, no reporter induction was seen when cells
were plated on collagen type I (Fig. 6). Finally, we ob-
served nuclear translocation of the p65 subunit when en-
dothelial cells were plated on osteopontin. As shown in
Fig. 7 A, most of the p65 NF-kB subunit was localized in
the nucleus when endothelial cells were plated on os-
teopontin. On the contrary, the staining remained local-
ized to the cytoplasm when cells were plated on polylysine
(Fig. 7 B). No staining was observed when nonimmune an-
tibody was used (Fig. 7 C). These data suggest that os-
teopontin is able to activate NF-kB activity in endothelial
cells.
Osteopontin Induction of NF-kB is avb3-dependent
We then asked if osteopontin-induced NF-kB activity was
avb3-dependent. Endothelial cells plated on osteopontin
were treated with F11 or a control antibody. As shown in
Fig. 8 A, when cells were treated for 8 h with F11 antibody,
NF-kB activity was markedly reduced compared with con-
trol treatment. This result suggests that the avb3 integrin
mediated osteopontin-induced NF-kB activity. We next
explored whether endothelial cell adhesion to immobi-
lized F11 was able to similarly regulate NF-kB. Fig. 8 B
shows that endothelial cells plated on surface-immobilized
F11 showed a considerably higher binding activity than
control cells. These results show that avb3 ligation alone is
sufficient to induce NF-kB activity.
Inhibition of NF-kB Activity Abolishes
Osteopontin-mediated Survival
To determine if nuclear translocation of the NF-kB het-
erodimer was necessary for avb3-mediated survival func-
tion, we overexpressed a nondegradable form of IkBa in
endothelial cells. Overexpression of a mutant form of
IkBa, in which the two serines (S 32 and 36) critical for
phosphorylation and subsequent degradation were mu-
Figure 3. avb3 integrin medi-
ates osteopontin-induced en-
dothelial cell survival. (A)
Cells were plated on os-
teopontin-coated surfaces in
serum-free medium. Soon af-
ter spreading (z2 h after
plating), F11 monoclonal an-
tibody (triangles) or mouse
IgG (squares) at the concen-
tration of 50 mg/ml were
added. Nuclear morphology
was assessed at 24, 48, and
72 h. (B) Cells were plated
on polylysine, osteopontin
(OPN), F11, or mouse IgG
(mIgG)-coated surfaces in
serum-free medium. 48 h af-
ter plating, cells were stained
with the nuclear dye Hoechst
33342, and nuclear morphol-
ogy was assessed. Data rep-
resent the average of tripli-
cates  6  SD of a representative
experiment.The Journal of Cell Biology, Volume 141, 1998 1088
tated to alanines, has been recently successfully used to in-
hibit NF-kB nuclear translocation (Brockman et al., 1995).
We generated a murine IkBa deletion construct where the
first 37 amino acids were deleted, thereby eliminating both
Ser 32 and Ser 36. This cDNA was cloned in MRE-pNeo
expression vector (Searle et al., 1985) downstream of a
synthetic, Zn-inducible promoter. We then transfected en-
dothelial cells and generated stable cell lines. NF-kB
inducibility was lost in two clones (RAECDN2 and
RAECDN5) upon treatment with 100 mM ZnSO4 for 16 h,
followed by treatment with IL1-b as measured by reporter
assay (Fig. 9 A). 100 mM of ZnSO4 was chosen since this
concentration gave maximal expression of the IkBa mu-
tant in serum-containing medium as determined by West-
ern blot analysis (data not shown).
We then asked whether overexpression of the mutant
IkBa and subsequent inhibition of NF-kB translocation
could abolish osteopontin-induced survival upon growth
factor withdrawal. To test this hypothesis, RAECDN2
cells were plated in serum-free medium on osteopontin-
coated surface, and were treated either with vehicle or 20
mM ZnSO4. In serum-free medium, 20 mM ZnSO4 was suf-
ficient to induce maximal expression of the IkBa mutant
(data not shown). As shown in Fig. 9 B, upon treatment
the osteopontin protective effect was completely abol-
ished, strongly suggesting that NF-kB activation by os-
teopontin is necessary for endothelial cell survival. Cells
that were transfected with vector alone did not show any
appreciable cell death when plated on osteopontin and
treated with vehicle or 20 mM ZnSO4 (data not shown),
thus confirming the specificity of the effect seen with the
mutant IkBa construct.
In a similar set of experiments, we tested whether inhibi-
tion of NF-kB translocation could abolish the protective
effect observed with other integrin ligands. As shown in
Fig. 9 C, only the protective effects of vitronectin and
immobilized  b3 antibody were abolished. In contrast,
RAECDN2 cells plated on fibronectin, laminin, and col-
lagen type I continued to be protected (Fig. 9 C). Thus,
these results indicate that NF-kB activation is necessary
for avb3-mediated endothelial cell survival, but a different
and at the moment unknown survival pathway is engaged
by b1-containing integrins.
Ras and Src, but not MEK and PI3-Kinase, Mediate 
NF-kB Induction by Osteopontin
In an effort to identify membrane proximal signal by
Figure 4. Endothelial cells plated on osteopontin have elevated
NF-kB binding activity. (A) Cells were plated on polylysine
(PDL) or osteopontin (OPN)-coated surfaces in serum-free me-
dium. 4 h after plating, nuclear protein extracts were harvested,
and EMSA was performed using a double-stranded 32P-labeled
consensus NF-kB oligomer. Adding a 100-fold excess of unla-
beled consensus NF-kB oligomer (COMP) completely inhibited
binding, and a 100-fold excess of unlabeled unrelated sequence
(UNCOMP) had no effect. (B) Cells were plated on osteopontin
(OPN), fibronectin (FN), and collagen type I (COLL I). 4 h after
plating, nuclear protein extracts were harvested, and EMSA was
performed using a double-stranded 32P-labeled consensus NF-kB
oligomer. (C) Cells were plated on polylysine (PDL) or os-
teopontin (OPN)-coated surfaces in serum-free medium. Nuclear
protein extracts were harvested at 2, 4, 6, and 8 h after plating,
and EMSA was performed using a double-stranded 32P-labeled
consensus NF-kB oligomer.
Figure 5. The p65 and p50
subunits form the NF-kB
complex induced by os-
teopontin. Nuclear extract
from endothelial cells plated
on osteopontin were incu-
bated with a double-stranded
32P-labeled consensus NF-kB
oligomer, followed by incu-
bation with polyclonal anti-
body against the p65 and p50
NF-kB subunits singly and
combined, and with control
rabbit IgG. Arrows indicate
the shifted bands.Scatena et al. NF-kB and Integrin-mediated Cell Survival 1089
which  avb3 integrin ligation leads to NF-kB activation,
dominant negative constructs for the GTP-binding protein
Ras (Ras-N17), for the kinase Src (kinase dead), and a
vector control were cotransfected with the NF-kB reporter
construct. As shown in Fig. 10 A, osteopontin-induced
NF-kB activity was completely inhibited by expression of
Ras-N17 and Src dominant negative constructs. In con-
trast, the specific MEK inhibitor PD58095 and the specific
PI3-kinase inhibitor LY-294002 did not effect osteopon-
tin-mediated NF-kB activity (Fig. 10 B). These inhibitors
were shown to be effective by Western blot (data not
shown). These results suggest that Ras and Src are proxi-
mal mediators of avb3-induced NF-kB activation.
Discussion
We have investigated the ability of ECM proteins to pro-
tect endothelial cells against apoptosis induced by serum
withdrawal. We found that different ECM molecules
played a role in cell survival under conditions of serum
withdrawal, suggesting that different classes of integrins
(b1 and b3) could mediate this function. In addition, we
were able to show that a neutralizing b3 integrin antibody
induced rounding and apoptosis when added in soluble
form to cells plated on osteopontin, a known avb3 ligand.
In contrast, a neutralizing b1 antibody had no effect. These
data support the hypothesis that osteopontin promotes en-
dothelial cell survival uniquely via the avb3 integrin. To ex-
plore the downstream mechanism of protection, we exam-
ined the activity of NF-kB, a recently described cell
survival factor (Beg and Baltimore, 1996; Liu et al., 1996;
Van Antwerp et al., 1996; Wang et al., 1996). We found
that integrin receptor ligation resulted in rapid NF-kB ac-
tivation in endothelial cells. Furthermore, we give func-
tional evidence that NF-kB nuclear translocation was re-
quired for osteopontin-induced endothelial cell survival,
but not for b1 integrin-mediated survival. Finally, we pro-
vide evidence that the small GTP-binding protein Ras and
the tyrosine kinase Src are required for osteopontin-
induced NF-kB activity. These results define a novel inte-
grin-mediated survival pathway leading from avb3 integrin
through Ras and Src to NF-kB in endothelial cells.
In vivo, inhibition of the avb3 integrin in angiogenic
vessels causes endothelial cell apoptosis (Brooks et al.,
1994b), suggesting that a specific interaction between en-
dothelial cells and an avb3 ligand(s) is required for sur-
vival. Here we show that avb3 ligands also protect endo-
thelial cells from apoptosis induced by serum withdrawal
Figure 6. Osteopontin induces NF-kB–dependent luciferase gene
expression. Endothelial cells were transfected with a NF-kB–respon-
sive luciferase reporter construct. Cells were plated on polylysine
(PDL), collagen type I (Coll type I), osteopontin (OPN), and
fibronectin (FN)-coated surfaces in serum-free medium. Cell ly-
sates were harvested, and luciferase activity was measured 8 h af-
ter plating on immobilized substrates. Data represent the average
of triplicates 6 SD of a representative experiment.
Figure 7. Osteopontin induces nuclear translocation of the p65
subunit. Cells were plated on osteopontin (A)- or polylysine (B)-
coated surfaces in serum-free medium. 2 h after plating, cells
were fixed and stained with a polyclonal anti-p65 subunit anti-
body. Bar, 10 mM. (C) Staining of cells plated on osteopontin
with control nonimmune serum. Bar, 20 mM.The Journal of Cell Biology, Volume 141, 1998 1090
in vitro. Osteopontin, vitronectin, and fibronectin were all
able to promote endothelial cell survival after serum with-
drawal. Moreover, the b1 ligands fibronectin, laminin, and
collagen type I were also able to protect against apoptosis
induced by serum deprivation, consistent with previous
studies in which apoptosis was induced by suspension
(Meredith et al., 1993; Re et al., 1994). Thus, different
classes of integrins and ligands are able to facilitate endo-
thelial survival under diverse conditions.
The mechanism by which integrin ligation leads to cell
survival is under intense investigation. It has been pro-
posed that integrin regulation of bcl2-family members
(Stromblad et al., 1996; Zhang et al., 1995), the PI3-kinase/
Akt pathway (Khwaja et al., 1997), and the MEKK-1/JNK
pathway (Cardone et al., 1997) may be important for cell
protective effects. Moreover, Day et al. (1997) suggest that
the activity of the tumor suppressor Rb is required for in-
duction of apoptosis in cells maintained in suspension
(anoikis), and some evidence suggests that avb3 integrin li-
gation in endothelial cells suppresses p53 binding activity
(Stromblad et al., 1996). These findings suggest that multi-
ple and potentially overlapping integrin-mediated survival
pathways exist.
Recently, several groups have suggested a key role of
Figure 8. Osteopontin-induced NF-kB binding activity is inhib-
ited by the b3 integrin antagonist F11. (A) Cells were plated on
osteopontin-coated (OPN) surfaces in serum-free medium. Soon
after spreading (z2 h after plating), F11 monoclonal antibody or
mouse-IgG (mIgG) were added at the concentration of 50 mg/ml.
10 h after plating, nuclear protein extracts were harvested, and
EMSA was performed using a double-stranded 32P-labeled con-
sensus NF-kB oligomer. (B) Cells were plated on polylysine
(PDL) or immobilized F11. 4 h after plating, nuclear protein ex-
tracts were harvested, and EMSA was performed using a double-
stranded 32P-labeled consensus NF-kB oligomer.
Figure 9. Inhibition of NF-kB nuclear translocation abolishes os-
teopontin-induced endothelial cell survival. (A) RAECDN2
clone was transfected with a NF-kB–responsive luciferase re-
porter construct. Cells were then treated for 16 h with either vehi-
cle or 100 mM of ZnSO4 (Zn) followed by a 1-h treatment with
IL1-b. Cell lysates were harvested, and luciferase activity was
measured. (B) RAECDN2 clone was plated on osteopontin-
coated surfaces in serum-free medium in the absence or presence
of 20 mM ZnSO4 (Zn). 16 h later, cells were stained with the nu-
clear dye Hoechst 33342, and nuclear fragmentation was as-
sessed. (C) RAECDN2 clone was plated on vitronectin (VN), fi-
bronectin (FN), laminin (LM), collagen type I (Coll I), and F11
monoclonal antibody–coated surfaces in serum-free medium in
the absence (vehicle) or presence of 20 mM ZnSO4 (Zn). 16 h
later, cells were stained with the nuclear dye Hoechst 33342, and
nuclear fragmentation was assessed. Data represent the average
of triplicates 6 SD of a representative experiment. Every experi-
ment was repeated with a separate clone (RAECDN5), and iden-
tical results were obtained.Scatena et al. NF-kB and Integrin-mediated Cell Survival 1091
NF-kB p65 in apoptosis inhibition (Beg and Baltimore,
1996; Liu et al., 1996; Van Antwerp et al., 1996; Wang et al.,
1996). In the p65 knockout mouse, embryonic lethality is
seen, and is most likely due to extensive apoptosis and ne-
crosis of the liver (Beg et al., 1995). In addition, cells with
functionally inactive NF-kB undergo apoptosis when chal-
lenged with TNFa (Beg and Baltimore, 1996; Liu et al.,
1996; Van Antwerp et al., 1996; Wang et al., 1996). How-
ever, the potential role of NF-kB in integrin-mediated sur-
vival has not previously been reported. In the present
studies, we observed a rapid and sustained activation of
NF-kB when endothelial cells were plated on osteopontin,
as measured by EMSA, nuclear translocation of the p65
subunit, and luciferase reporter assay. We also determined
that  avb3 was required for osteopontin-induced NF-kB
activity, since adding F11 antibody to endothelial cells
spread on osteopontin inhibited this activity, and cells
plated on immobilized F11 showed elevated NF-kB activ-
ity. This result correlated with the observation that soluble
b3 antagonist inhibited osteopontin-induced endothelial
cell survival. Indeed, NF-kB activity was required for os-
teopontin-induced survival, since inhibition of NF-kB nu-
clear translocation by the nonphosphorylatable IkBa com-
pletely blocked the protective effect of osteopontin. While
several previous studies have correlated NF-kB activation
with integrin ligation (McGilvray et al., 1997; Qwarnstrom
et al., 1994; Rosales and Juliano, 1996), ours is the first to
demonstrate a functional role for integrin-induced NF-kB
in cell survival.
Several signaling pathways leading from integrin ligation
to cell function have been recently identified (Schlaepfer and
Hunter, 1996). Engagement of integrins by the ECM
causes organization of a complex structure, termed focal
adhesion, on the cytoplasmic side of the plasma membrane
(Schwartz et al., 1995). The tyrosine kinase FAK appears
to play a central role in integrin signal transduction. FAK
activation has been linked to cytoskeletal organization,
regulation of small GTP-binding proteins like Rho and
Ras, and interaction with intracellular proteins like c-Src
and c-Fyn, Grb2/Sos, and PI-3 kinase. These data suggest
that FAK and its downstream targets are important relays
in integrin-mediated signaling (Schaller and Parsons, 1994).
Our studies indicate that both Ras and Src are required
for avb3-mediated NF-kB activation in endothelial cells.
Overexpression of Ras and Src dominant negative mu-
tants specifically inhibited osteopontin-induced NF-kB ac-
tivation. In contrast, inhibitors of PI-3 kinase and MEK,
which were previously shown to block suspension-induced
death (Khwaja et al., 1997; Wary et al., 1996), failed to
block osteopontin-induced NF-kB activation. These data
suggest that the survival pathway initiated by avb3 is dis-
tinct from those previously identified (Khwaja et al., 1997;
Wary et al., 1996). In addition, in the present studies, b1 li-
gation was unable to induce NF-kB activation, and the
protective effect of b1 ligands was not blocked when NF-kB
was inhibited by nonphosphorylatable IkBa. These find-
ings indicate that at least two distinct ECM-mediated pro-
tective pathways exist in endothelial cells: one mediated
by b3 integrins, and another mediated by b1 integrins.
Our studies are consistent with previous studies showing
that overexpression of Ras induced activation of NF-kB in
NIH3T3 fibroblasts and Jurkat T-lymphoma cells (Perona
et al., 1997). However, overexpression of activated Ras
and Src appeared to inhibit b1 ligation-induced NF-kB ac-
tivation in human monocytic cells (Rosales and Juliano,
1996), and MAPK appeared to mediate a4b1-induced NF-kB
activation in the same cell type (McGilvray et al., 1997).
Thus, the effect of integrins on NF-kB activation and the
signaling pathways involved may be cell type–specific.
Our studies support the hypothesis that intracellular sig-
naling initiated by ligating avb3 leads to NF-kB activation.
NF-kB normally exists in an inactive form in the cyto-
plasm complexed to its inhibitor, IkB, a family of related
ankyrin-containing proteins. Phosphorylation of IkB pro-
motes its ubiquitination and subsequent degradation by
the proteosome machinery, thereby unmasking the NF-kB
nuclear targeting sequence. It is likely that avb3 integrin li-
gation indirectly regulates IkB phosphorylation. Several
Figure 10. Ras and Src mediate osteopontin-induced NF-kB acti-
vation. (A) Cells were cotransfected with the NF-kB–responsive
luciferase reporter construct and either the RasN17 construct, the
Src kinase dead (SrcDN) construct, or vector alone. Cells were
then plated on polylysine (PDL)- or osteopontin (OPN)-coated
surfaces in serum-free medium. Cell lysates were harvested, and
luciferase activity was measured 8 h after plating on immobilized
substrates. (B) Cells were transfected with the NF-kB–responsive
luciferase reporter construct. Cells were then plated on polyly-
sine (PDL)- or osteopontin (OPN)-coated surfaces in serum-free
medium. Cells plated on osteopontin were treated with the indi-
cated concentrations of LY-294002 and PD98059 compounds.
Cell lysates were harvested, and luciferase activity was measured
8 h after plating. Data represent the average of triplicates 6 SD
of a representative experiment.The Journal of Cell Biology, Volume 141, 1998 1092
kinases have been shown potentially to regulate IkB phos-
phorylation: protein kinase C, MEKK1, NIK (a member
of the MAPK family; Baldwin, 1996; Lee et al., 1997; Mali-
nin et al., 1997), and the recently identified IKK-1 and
IKK-2 (Mercurio et al., 1997). Which, if any, of these ki-
nases is involved in NF-kB activation in our system is cur-
rently under investigation.
How might NF-kB regulate cell survival? Previous stud-
ies showing that cells lacking NF-kB become sensitive to
TNFa treatment suggest that NF-kB may regulate anti-
apototic genes. TNFa regulates many genes, and some of
them are known to suppress apoptosis like the endothe-
lial-specific bcl-2 homolog A1 (Karsan et al., 1996). In-
deed, Karsan et al. (1996) showed that A1 inhibits not only
TNFa-induced endothelial cell death, but also ceramide-
induced endothelial cell apoptosis. At the moment, we do
not know if A1 or other antiapoptotic bcl-2 family mem-
bers are regulated by NF-kB, but it is a possibility since in-
tegrin ligation correlates with their upregulation (Strom-
blad et al., 1996; Zhang et al., 1995). Another candidate is
manganous superoxide dismutase. This enzyme has been
shown to be antiapoptotic and TNFa-induced (Liu et al.,
1996). Interestingly, MnSOD Drosophila homolog has
been shown to have NF-kB–like sites in the 59-untrans-
lated region (Duttaroy et al., 1997). Baculovirus inhibitors
of apoptosis mammalian homologs (cIAPs) are also candi-
dates  (Uren et al., 1996). cIAPs are caspase inhibitors
probably by directly binding and inactivating these en-
zymes (Deveraux et al., 1997). Recently, cIAP1 has been
shown to be NF-kB inducible (Chu et al., 1997). Finally, a
new class of molecules (casper/I-FLICE/cFlip) containing
caspase and death effector domain has been described re-
cently (Hu et al., 1997; Irmler et al., 1997; Shu et al., 1997).
It appears that different splice variants of these molecules
can either inhibit or stimulate apoptosis. Nothing is known
about the regulation casper/I-FLICE/cFlip; therefore, it
will be a challenge to explore a possible NF-kB involvement.
From this study, a pathway linking avb3 integrin ligation,
NF-kB, and endothelial cell survival has emerged. This
pathway may be important in the angiogenesis process
since the avb3 integrin is expressed in proliferating angio-
genic endothelial cell, and is required for their survival
(Brooks et al., 1994a; Brooks et al., 1994b). Moreover, avb3
antagonists prevent vessel maturation in developing quail
(Drake et al., 1995). While it is not yet clear if NF-kB is
generally important in angiogenesis in vivo, NF-kB activa-
tion has been described in regenerating rat aortic endothe-
lial cells in vivo (Lindner and Collins, 1996), and nuclear
NF-kB was detected in activated endothelial cells overly-
ing atherosclerotic plaques (Brand et al., 1996). Further-
more, in vitro studies support a role for NF-kB in angio-
genic processes. Both capillary tube formation and NF-kB
activity were induced by 12(R)-HETrE in cultured rabbit
coronary microvascular endothelial cells. Moreover, inhi-
bition of NF-kB activation in these cells resulted in inhibi-
tion of 12(R)-HETrE-induced tube formation (Stoltz et al.,
1996).  Similarly, human microvascular endothelial cells
were shown to undergo both NF-kB activation and tubular
morphogenesis in response to hydrogen peroxide treat-
ment, and NF-kB antisense oligonucleotides completely
blocked hydrogen peroxide-induced tube formation (Shono
et al., 1996).
Osteopontin and its interactions with endothelial cells
via the avb3 integrin are of particular interest since we re-
cently identified osteopontin as an endothelial cell product
in a subset of vasa vasorum in the human atherosclerotic
plaque and granulation tissue (O’Brien et al., 1994). avb3
was also expressed in the same type of vessels (Hoshiga et
al., 1995). We have also shown that osteopontin synthesis
was dramatically increased in regenerating large vessel en-
dothelium in vivo, and the b3 integrin subunit was coordi-
nately upregulated (Liaw et al., 1995). As mentioned
above, nuclear translocation of the NF-kB p65 subunit was
recently observed in regenerating endothelial cells using
the same animal model (Lindner and Collins, 1996).
In conclusion, we have provided evidence that os-
teopontin mediates endothelial cell survival uniquely via
the avb3 integrin. Furthermore, we have presented func-
tional evidence that the NF-kB pathway is fundamental
for b3-mediated inhibition of apoptosis. Given the critical
role of avb3 integrin during the angiogenesis process
(Brooks et al., 1994a; Brooks et al., 1994b; Brooks et al.,
1995; Drake et al., 1995; Friedlander et al., 1996), it is
tempting to speculate that osteopontin may act as one of
the endogenous ligands for avb3 integrin during angiogen-
esis. Finally, we have demonstrated that b1 ligand–medi-
ated endothelial survival is not NF-kB dependent, suggest-
ing that distinct b3 and b1-mediated survival pathways
exists.
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